WNT pathway inhibitors

Product Name Product Description Specification
SL#003 Wnt/β-catenin Pathway Inhibitors
Release: 04/16/2016

Wnt cascade is mis-regulated in many human malignancies including 90% of colon cancers; therefore, blocking of Wnt signaling is considered an attractive therapeutic approach for colorectal cancer treatment [1,2].

In library: WNT pathway inhibitors